The positive and negative syndrome scale (PANSS) and Andreasen remission criteria have contextually been used to characterize schizophrenia symptoms in clinical trials. However, few studies have investigated the relationships among the possible scores of these two psychometric tools. The present study intends to address this topic starting from a theoretical combinatorial analysis of the possible dispositions with replacement that could be generated by the two scales. The results indicated that the probability to fully accomplish Andreasen remission criteria is enclosed in a very narrow window, because of the huge amount of possible dispositions with replacement of PANSS. Conversely, the probability to accomplish the remission criteria only for the general psychopathology PANSS subscale was unexpectedly elevate. The observed differences among the probabilities to attain remission within PANSS scale are possibly related to the approach in modeling schizophrenia syndrome. The symptomatic features of individuals enrolled in clinical trials should be carefully analyzed when both PANSS and Andreasen remission criteria are used to assess schizophrenia symptoms.

On the positive and negative syndrome scale and remission in schizophrenia

Palomba M;Marchese G
2016

Abstract

The positive and negative syndrome scale (PANSS) and Andreasen remission criteria have contextually been used to characterize schizophrenia symptoms in clinical trials. However, few studies have investigated the relationships among the possible scores of these two psychometric tools. The present study intends to address this topic starting from a theoretical combinatorial analysis of the possible dispositions with replacement that could be generated by the two scales. The results indicated that the probability to fully accomplish Andreasen remission criteria is enclosed in a very narrow window, because of the huge amount of possible dispositions with replacement of PANSS. Conversely, the probability to accomplish the remission criteria only for the general psychopathology PANSS subscale was unexpectedly elevate. The observed differences among the probabilities to attain remission within PANSS scale are possibly related to the approach in modeling schizophrenia syndrome. The symptomatic features of individuals enrolled in clinical trials should be carefully analyzed when both PANSS and Andreasen remission criteria are used to assess schizophrenia symptoms.
2016
Inglese
11th IEEE International Symposium on Medical Measurements and Applications, MeMeA 2016;
5
http://www.scopus.com/record/display.url?eid=2-s2.0-84985036786&origin=inward
Sì, ma tipo non specificato
15/05/2016 18/05/2016
Benevento
Schizophrenia
psychometry
scale
2
none
Nicotra E.F.; Casu G.; Piras S.; Palomba M.; Marchese G.
273
info:eu-repo/semantics/conferenceObject
04 Contributo in convegno::04.01 Contributo in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/404869
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? ND
social impact